Term ends Dec 19, 2029 · High confidence
20-year base term ends Dec 16, 2029
Held by Endo Ventures Unlimited Company
Filed Dec 16, 2009 as application 12/639,664 · Granted Jul 16, 2013
Base term plus 3 days of patent term adjustment (USPTO delay)
Today
2009
2029
Clock starts
Dec 16, 2009
Dec 16, 2009
Term ends
Dec 19, 2029
Dec 19, 2029
Granted
Jul 16, 2013
Jul 16, 2013
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
3
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,486,448, to Dec 19, 2029. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 3 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 16, 2009, when this application, 12/639,664, was filed | Dec 16, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +3 days, USPTO patent term adjustment record | Dec 19, 2029 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,486,448) | resolves to Dec 19, 2029, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 19, 2029 | High confidence |
This family
| US 8,486,449 | this patent Dec 2029 | Dec 2029 |
| US 8,685,447 | Lapsed on the fee record Apr 2026 | Apr 2026 |
| US 8,927,013 | In force Dec 2028 | Dec 2028 |
| US 8,927,014 | In force Dec 2028 | Dec 2028 |
| Application 14/560,933 | Abandoned not computed | not computed |
| Application 15/004,461 | Abandoned not computed | not computed |
| Application 15/700,871 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
The 40 most recent of 48 recorded documents are shown; the 8 earliest are not. Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 26, 2013 Reel 30088, frame 806 | Labopharm Inc. | 9254-0145 Quebec Inc. | Change of Name |
| Mar 26, 2013 Reel 30088, frame 862 | Labopharm Inc. | Paladin Labs Inc. | Merger |
| Mar 26, 2013 reel/frame not recorded | El-jammal, Ali | 9254-0145 Quebec Inc. (Formerly Known as Labopharm Inc.) - Partial Interest (Entire Interest Owned by 9254-0145 Quebec Inc., Paladin Labs Europe Limited and Labopharm (Barbados) Limited) | Assignment of Assignor's Interest |
| Mar 26, 2013 reel/frame not recorded | El-jammal, Ali | Paladin Labs Europe Limited (Formerly Known as Labopharm Europe Limited) - Partial Interest (Entire Interest Owned by 9254-0145 Quebec Inc., Paladin Labs Europe Limited and Labopharm (Barbados) Limited) | Assignment of Assignor's Interest |
| Mar 26, 2013 reel/frame not recorded | El-jammal, Ali | Labopharm (Barbados) Limited - Partial Interest (Entire Interest Owned by 9254-0145 Quebec Inc., Paladin Labs Europe Limited and Labopharm (Barbados) Limited) | Assignment of Assignor's Interest |
| Mar 26, 2013 reel/frame not recorded | Duffayet, Frederic | 9254-0145 Quebec Inc. (Formerly Known as Labopharm Inc.) - Partial Interest (Entire Interest Owned by 9254-0145 Quebec Inc., Paladin Labs Europe Limited, and Labopharm (Barbados) Limited) | Assignment of Assignor's Interest |
| Mar 26, 2013 reel/frame not recorded | Duffayet, Frederic | Paladin Labs Europe Limited (Formerly Known as Labopharm Europe Limited) - Partial Interest (Entire Interest Owned by 9254-0145 Quebec Inc., Paladin Labs Europe Limited, and Labopharm (Barbados) Limited) | Assignment of Assignor's Interest |
| Mar 26, 2013 reel/frame not recorded | Duffayet, Frederic | Labopharm (Barbados) Limited - Partial Interest (Entire Interest Owned by 9254-0145 Quebec Inc., Paladin Labs Europe Limited, and Labopharm (Barbados) Limited) | Assignment of Assignor's Interest |
| Mar 26, 2013 reel/frame not recorded | Bichara, Ali; Rahmouni, Miloud; Rustom, Shams; Sant, Vinayak; Gervais, Sonia; Ndong, Jean-michel; Smith, Damon | 9254-0145 Quebec Inc. (Formerly Known as Labopharm Inc.) - Partial Interest (Entire Interest Owned by 9254-0145 Quebec Inc., Paladin Labs Europe Limited, and Labopharm (Barbados) Limited) | Assignment of Assignor's Interest |
| Mar 26, 2013 reel/frame not recorded | Bichara, Ali; Rahmouni, Miloud; Rustom, Shams; Sant, Vinayak; Gervais, Sonia; Ndong, Jean-michel; Smith, Damon | Paladin Labs Europe Limited (Formerly Known as Labopharm Europe Limited) - Partial Interest (Entire Interest Owned by 9254-0145 Quebec Inc., Paladin Labs Europe Limited, and Labopharm (Barbados) Limited) | Assignment of Assignor's Interest |
| Mar 26, 2013 reel/frame not recorded | Bichara, Ali; Rahmouni, Miloud; Rustom, Shams; Sant, Vinayak; Gervais, Sonia; Ndong, Jean-michel; Smith, Damon | Labopharm (Barbados) Limited - Partial Interest (Entire Interest Owned by 9254-0145 Quebec Inc., Paladin Labs Europe Limited, and Labopharm (Barbados) Limited) | Assignment of Assignor's Interest |
| May 26, 2020 Reel 53548, frame 239 | Endo Global Ventures; Endo Ventures Limited; Paladin Labs Inc. | Wilmington Trust, National Association | Confirmatory Grant of Security Interest in United States Patents |
| Sep 17, 2021 Reel 57538, frame 893 | Endo Ventures Limited; Endo Global Ventures; Paladin Labs Inc. | Wilmington Trust, National Association | Confirmatory Grant of Security Interest in United States Patents |
| Mar 5, 2024 Reel 66732, frame 137 | Endo Ventures Unlimited Company | Operand Pharmaceuticals III Limited | Assignment of Assignor's Interest |
| Mar 5, 2024 Reel 66732, frame 396 | Endo Ventures Limited | Endo Ventures Unlimited Company | Change of Name |
| Mar 5, 2024 Reel 66732, frame 413 | Operand Pharmaceuticals III Limited | Endo Operations Limited | Change of Name |
| Apr 23, 2024 Reel 67203, frame 281 | Paladin Labs Inc. | Paladin Pharma Inc. | Assignment of Assignor's Interest |
| Apr 24, 2024 Reel 67216, frame 376 | Wilmington Trust, National Association | Endo Global Aesthetics Limited; Endo Global Ventures; Endo Ventures Bermuda Limited; Endo Ventures Limited; Paladin Labs Inc. | Release of Security Interest |
| Apr 24, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Global Aesthetics Limited | Release of Security Interest |
| Apr 24, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Global Ventures | Release of Security Interest |
| Apr 24, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Ventures Bermuda Limited | Release of Security Interest |
| Apr 24, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Ventures Limited | Release of Security Interest |
| Apr 24, 2024 reel/frame not recorded | Wilmington Trust, National Association | Paladin Labs Inc. | Release of Security Interest |
| Apr 25, 2024 Reel 67221, frame 958 | Wilmington Trust, National Association | Endo Global Aesthetics Limited; Endo Global Ventures; Endo Ventures Bermuda Limited; Endo Ventures Limited; Paladin Labs Inc. | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Global Aesthetics Limited | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Global Ventures | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Ventures Bermuda Limited | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Ventures Limited | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Paladin Labs Inc. | Release of Security Interest |
| Apr 27, 2024 Reel 67245, frame 714 | Paladin Pharma Inc. | Endo Operations Limited | Assignment of Assignor's Interest |
| Jun 20, 2024 Reel 67778, frame 988 | Paladin Labs (Barbados) Inc. | Endo Ventures Unlimited Company (F/K/A Endo Ventures Limited) | Assignment of Assignor's Interest |
| Jun 20, 2024 Reel 67779, frame 54 | Paladin Labs Europe Limited | Endo Ventures Unlimited Company (F/K/A Endo Ventures Limited) | Assignment of Assignor's Interest |
| Jun 20, 2024 Reel 67994, frame 211 | Endo Ventures Limited | Endo Ventures Unlimited Company | Change of Name |
| Jul 19, 2024 Reel 68461, frame 692 | Endo Biologics Limited; Endo Operations Limited | Goldman Sachs Bank USA | Security Interest |
| Jul 19, 2024 Reel 68031, frame 59 | Endo Operations Limited | Goldman Sachs Bank USA, as Collateral Agent | Security Interest |
| Jul 19, 2024 Reel 68031, frame 202 | Endo Operations Limited | Computershare Trust Company, National Association | Security Interest |
| Jul 22, 2024 Reel 68469, frame 1 | Endo Biologics Limited; Endo Operations Limited | Computershare Trust Company, National Association | Security Interest |
| Apr 17, 2025 Reel 70887, frame 702 | Paladin Pharma Inc. | Endo Operations Limited | Corrective Assignment to Correct the Application Number Previously Recorded at Reel: 67245 Frame: 714. Assignor(S) Hereby Confirms the Assignment. |
| Jul 23, 2025 Reel 71804, frame 377 | Computershare Trust Company, National Association | Endo Operations Limited | Release of Security Interest |
| Jul 23, 2025 Reel 71804, frame 384 | Goldman Sachs Bank USA | Endo Operations Limited | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Dec 2029
Term ends Dec 19, 2029. No further fees fall due before then
Note
The 3 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,486,448, ends no earlier than this term, so it caps nothing.
Citations
68
later US patents cite this one
That is top 10% of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.